Yes that's right, unfortunately SAE's happen more frequently than most people would be aware of. From my understanding there was research that indicated the lack of reporting by a lot of pharma's on the SAE and AE fronts. While it is a set back in the way of a delay I wouldn't expect any major issues with continuing the trials given the fact that to my knowledge there hasn't been any SAE'S or AE'S from PTX-200 trials. Unfortunately the people undertaking the treatment as apart of these trials are very, very ill people and while we all hope for the best outcome we don't always get it. These people are heroic in their undertakings and not enough acknowledgment is given to these people who are very selfless in giving what they can for the betterment of others.
PTX Price at posting:
5.8¢ Sentiment: Buy Disclosure: Held
